TDC
OFIX icon

Thompson Davis & Co’s Orthofix Medical OFIX Stock Holding History

Thompson Davis & Co’s Portfolio OFIX Stock Details OFIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-266
Closed -$15K – 689
2017
Q4 		$15K Buy
+266
New +$13.8K 0.04% 359
2016
Q4 		– Sell
-125
Closed -$5K – 1180
2016
Q3 		$5K Hold
125
– – 0.01% 838
2016
Q2 		$5K Buy
+125
New +$5.43K 0.01% 787

Other funds holding OFIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return

Thompson Davis & Co's OFIX Position: Q1 2018 in Review

Thompson Davis & Co sold out of Orthofix Medical (OFIX) in Q1 2018, closing a stake of 266 shares — an estimated $15K sold.

Thompson Davis & Co first reported a position in OFIX in Q2 2016 and held it in 3 quarters. The position peaked at $15K in Q4 2017. 178 funds tracked by Wall St. Rank hold OFIX as of Q1 2018.

  • Thompson Davis & Co reported no remaining Orthofix Medical position as of Q1 2018 after selling out during the quarter.
  • Thompson Davis & Co sold 266 Orthofix Medical shares in Q1 2018, an estimated $15K.
  • Thompson Davis & Co first reported a position in Orthofix Medical in Q2 2016 and held it in 3 quarters.
  • Thompson Davis & Co's Orthofix Medical position peaked at $15K in Q4 2017.
  • 178 funds tracked by Wall St. Rank held Orthofix Medical as of Q1 2018.

Based on Thompson Davis & Co's 13F filing for Q1 2018, filed 2 May 2018.